Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Lymphoma Clinical Trials
Lymphoma clinical trials are recruiting across 209 cities. Here are the cities with the most active studies:
Lymphoma Trial Phases
61 research organizations are sponsoring lymphoma trials.
About Lymphoma
Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.
Clinical trials are advancing new treatments for lymphoma. Currently, 100 studies are recruiting a combined 68,794 participants across the United States. Research is being conducted by 61 organizations including Stanford University, OWKIN, Mayo Clinic and 58 others.
2026 Lymphoma Research Landscape
As of July 2026, the lymphoma clinical trial landscape includes 100 actively recruiting studies across 209 cities in the United States. These studies are collectively seeking 68,794 participants, with an average enrollment target of 688 per study.
The research spans multiple phases of development: 29 studies are in PHASE2, 28 studies are in PHASE3, 27 studies are in PHASE1, 5 studies are in NA, 3 studies are in PHASE4. The presence of Phase 3 trials indicates that some lymphoma treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 61 different organizations, including Stanford University, OWKIN, Mayo Clinic, University of Alabama at Birmingham, ECOG-ACRIN Cancer Research Group, and 56 others. The large number of sponsors reflects significant research interest and investment in lymphoma treatment advancement.
Geographically, lymphoma trials are most concentrated in Duarte, California (26 trials); New York, New York (23 trials); Phoenix, Arizona (15 trials); Boston, Massachusetts (15 trials); Birmingham, Alabama (14 trials) and 7 other cities.
Featured Lymphoma Studies
Highlighted recruiting studies for lymphoma, selected by enrollment size and research scope.
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.
A Non-interventional, International, Multicentre Clinical Research Study to Build the Largest Collection of Multimodal Data (Including Clinical Data, Imaging Data and Omics Data) in Oncology
Cancer is amongst the leading causes of disease-related morbidity and mortality. A major challenge in cancer treatment is the development of biology-informed, personalised treatment strategies. Recent advances in artificial intelligence (AI) and next-generation sequencing (NGS) technologies have shed further insights into disease biology and treatment pathways, thus identifying new, precision medi...
Family Study of Lymphoproliferative Disorders
Blood and lymph node cancers can begin in either the lymphatic tissues (as in the case of lymphoma) or in the bone marrow (as with leukemia and myeloma), and they all are involved with the uncontrolled growth of white blood cells. There are many subtypes of these cancers, e.g., chronic lymphocytic leukemia and non-Hodgkin lymphoma. Since there is evidence that these cancers cluster in families, th...
Frequently Asked Questions About Lymphoma Clinical Trials
Are there lymphoma clinical trials near me?
Yes, there are 100 lymphoma clinical trials currently recruiting across 209+ cities in the United States, including Duarte, California; New York, New York; Phoenix, Arizona. Browse the studies above to find one at a location convenient for you.
How do I join a lymphoma clinical trial?
To join a lymphoma clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are lymphoma clinical trials free?
Yes, participation in lymphoma clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of lymphoma treatments are being studied?
Current lymphoma clinical trials are testing a range of approaches across PHASE2 (29 studies), PHASE3 (28 studies), PHASE1 (27 studies), NA (5 studies), PHASE4 (3 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 61 research organizations.
Is it safe to participate in lymphoma clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 18, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 18, 2026 · Data from ClinicalTrials.gov